Paul Kelly
Directeur/Membre du Conseil chez RELMADA THERAPEUTICS, INC.
Fortune : 692 992 $ au 30/04/2024
Profil
Paul Kelly is currently a Director at Relmada Therapeutics, Inc. He previously worked as a Director at VisionGate, Inc. and as an Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. He also worked as an Equity Analyst at Mabon Securities Corp.
and as an Analyst at ING Barings LLC.
Mr. Kelly received his undergraduate degree from Brown University and his MBA from the University of Rochester Simon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC
0,62% | 27/03/2024 | 187 295 ( 0,62% ) | 692 992 $ | 30/04/2024 |
Postes actifs de Paul Kelly
| Sociétés | Poste | Début |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/11/2015 |
Anciens postes connus de Paul Kelly
| Sociétés | Poste | Fin |
|---|---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Analyst-Equity | 25/07/2002 |
| Mabon Securities Corp. | Corporate Officer/Principal | - |
VisionGate, Inc.
 VisionGate, Inc. Medical SpecialtiesHealth Technology VisionGate, Inc. provides in-vitro automated 3D cell structure and analysis solutions. It focuses on early detection and prevention of lung cancer. The firm’s attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. The company was founded by Alan C. Nelson and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | - |
| ING Barings LLC | Analyst-Equity | - |
Formation de Paul Kelly
| Brown University | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
| ING Barings LLC | Finance |
VisionGate, Inc.
VisionGate, Inc. Medical SpecialtiesHealth Technology VisionGate, Inc. provides in-vitro automated 3D cell structure and analysis solutions. It focuses on early detection and prevention of lung cancer. The firm’s attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. The company was founded by Alan C. Nelson and is headquartered in Phoenix, AZ. | Health Technology |
| Mabon Securities Corp. | Finance |
